Tumours of the Urinary System (Prostate + Testicular Cancer) Flashcards

1
Q

What is the commonest cancer diagnosed in men?

A

Prostate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

5 aetiologies/risk factors for prostate cancer?

A
  • Age
  • Race/ethnicity - African or Afro-Caribbean men living in Western countries vs East Asian or Asian men living in Western countries
  • Geography - Northwestern Europe/Nort America/Caribbean/Australia vs Asia/Africa/Central + South America
  • Family history - first degree relative 2x risk; HPC1; BRCA1 + 2
  • Food (only probable) - selenium, lycopenes/carotenoids, vit E, omega 3 FA
  • Drugs - Finasteride
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Review of McNeal’s prostatic zones

A

Transition zone

Central zone

Peripheral zone

Anterior fibromuscular stroma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Where does prostate cancer most commonly arise?

A

Peripheral zone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What do most prostate cancers present as clinically?

A

Asymptomatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How is prostate cancer diagnosed?

A

Through opportunistic PSA testing (not screening!)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the diagnostic triad of prostate cancer?

A

PSA (prostate-specific antigen)

Digital rectal examination

TRUS-guided prostate biopsy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is PSA?

A

Prostate-specific antigen

(not necessarily cancer specific!)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Give presenting symptoms of local disease in prostate cancer?

A
  • Weak stream*
  • Hesitancy*
  • Sensation of incomplete emptying*
  • Frequency*
  • Urgency*
  • Urge incontinence*
  • UTI*
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Give presenting symptoms of locally invasive disease in prostate cancer?

A

Haematuria

Perineal adn suprapubic pain

Impotence

Incontinence

Loin pain or anuria resulting from obstruction of the ureters

Symptoms of renal failure

Heamospermia

Rectal symptoms inc tenesmus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What percentage of newly diagnosed prostate cancers are localised?

A

80%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Give presenting features of DISTANT METASTASES in prostate cancer

A
  • Bone pain/sciatica
  • Paraplegia secondary to spinal cord compression
  • Llymph node enlargement
  • Lymphoedema, particularly in the lower limbs
  • Loin pain or anuria due to obstruction of the ureters by lymph nodes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Give the presenting symptoms of WIDESPREAD METASTASES in prostate cancer

A
  • Lethargy (e.g. due to anaemia, uraemia)
  • Weight loss and cachexia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

MCQ - what is the commonest mode of presentation for prostate cancer?

A

Asymptomatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Why is prostate cancer not screened for?

A

Wilson-Junger criteria not met

Level 1 evidence (i.e. RCTs and meta-analysis) that screening does not imprive cancer-specific mortality (compared with standard practice)

Screening leads to over-diagnosis and over-treatment of harmless cancers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q
A
17
Q

How to avoid under treatment of aggressive cancers?

A

Ad-hoc PSA testing !!

18
Q

What does Kllikrein serine protease (prostate-specific protein) do? What is it produced by?

A

Liquifies semen

The prostate glands - may leak into serum

19
Q

What is the normal serum range for PSA?

A

Normal serum range 0-4.0ug/mL

20
Q

How do PSA levels change with age? Give the age-related ranges

A

Increase with age

<50 yrs: 2.5 is upper limit

50-60 yrs: 3.5 is upper limit

60-70 yrs: 4.5 is upper limit

>70 yrs: 6.5 is upper limit

21
Q

Other than BPH and prostate cancer, what else can cause PSA elevations?

A

UTI

Chronic prostatitis

Instrumentation (e.g. catheterisation)

Physiological (e.g. ejaculation)

Recent urological procedure

22
Q

What is the half-life of PSA?

If a repeat PSA is needed, when should recheck be done?

A

2.2 days

Recheck in at least 3 weeks

23
Q

Levels of PSA and cancer probability (PPV):

A

0-1.0: 5%

  1. 0-2.5: 15%
  2. 5–4.0: 25%
  3. 0-10: 40%

>10: 70%

24
Q

How is prostate cancer graded?

A

Gleason Grading

Score 3-5 (well to poorly differetiated)

Then summated to give Gleason SUM score e.g. 3 + 4 = 7 (3 being most common/biggest area; 4 being second most common when looking at cells)

Useful prognostically to determine aggressiveness of cancer - guides treatment

25
Q

What is the gleason sum score now being changed to?

A

ISUP grade group

3+3 = 6 -> 1

3+4 = 7 -> 2

4+3 = 7 -> 3

8 = 4

9 and 10 = 5

(2 is better prognosis than 3 because bigger area of 3)

26
Q

Give the 4 stages that prostate cancer is divided into for treatment and prognosis

A
  • Localised*
  • Locally advanced*
  • Metastatic*
  • Hormone refractory*
27
Q

How is localised prostate cancer staged? (what investigations)

A

Digital rectal examination (local staging)

PSA

Transrectal US guided biopsies

CT (regional and distant staging)

MRI (local staging)

28
Q

Staging of localized prostate cancer by DRE

A

T2b more than 50% of one lobe compared to T2a which is less than 50%

T4 adjacent organs often the bladder or rectum

29
Q

Give the 3 methods for treatment of localised prostate cancer

A
  • Watchful waiting
  • Radiotherapy: external-beam, brachytherapy
  • Radical prostatectomy: open, laparoscopic, robotic

(others under inv = cryotherapy, thermotherapy)

30
Q

Give the 5 methods of treatment for locally advanced prostate cancer

A
  • Watchful waiting
  • Hormone therapy follwoed by surgery
  • Hormone therpay followed by radiation
  • Hormone therapy alone
  • Intermitted hormone therapy (clinical research)
31
Q

Give the 4 types of hormonal therapy for prostate cancer

A
  • Surgical castration (i.e. bilateral orchidectomy)
  • Chemical castration (i.e. LHRH analogue - goserlin, leuprorelin (causes tumour flare in first week - need anti-androgen); or LNRH antagonists) (acts on pituitary stops ADH going to testis to make testosterone)
  • Anti-androgens - inhibits androgen receptors on the testis
  • Oestrogens (i.e. diethylstilboestrol) - inhibits LHRH and testosterone secretion, inactivates androgens and has direct cytotoxic effect on prostatic epithelial cells
32
Q

Give the complications of metastatic and hormone refractory prostate cancer

A
  • Bone: pain, pathological fractures, anaemia, spinal cord compression
  • Rectal: constipation, bowel obstruction
  • Ureteric: obstruction resulting in renal failure
  • Pelvic lymphatic obstruction: lymphoedema, DVT
  • Lower UTI: haematuria, acute retention
33
Q

What is the mainstay of treatment for metastatic and hormone refractory prostate cancer?

A

Immediate hormonal therapy

34
Q

What is the supportive treatment for metastatic and hormone refractory prostate cancer?

A

Palliaitive radiotherapy to bony metastases, colostomy, nephrostomy, zoledronic acid, palliative care support

35
Q

When will hormone refractory stage be reached in metastatic prostate cancer?

A

In 18-24 months of treatment

–Diethylstilboestrol can be tried (high risk of thromboembolic and cardiovascular complications); median response time 4 months

–Docetaxel has survival benefit of 3 months

–Median survival of HRPC stage is 10 months

36
Q

Summary treatment of localised disease

A
37
Q

Stages and prognosis of prostate cancer

A